文献速递临床试验与 GCP

为期两周的每日两次棱镜适应治疗不能改善帕金森病的姿势或步态:一项双盲随机对照试验

Two weeks of twice-daily prism adaptation treatment does not improve posture or gait in Parkinson's disease: a double-blind randomized controlled trial.
PubMed 文献 · Trials · 2021-11-25

该平行双盲假对照随机试验纳入40-85岁符合特定标准的特发性帕金森病患者,比较两周每日两次棱镜适应与假治疗对姿势控制和步态的影响。结果显示棱镜适应组仅在稳定性极限测试中前进步速增加,其余结局指标均无组间差异,未产生功能性改善。

要点

  • 棱镜适应组稳定性极限测试前进步速增加(治疗前M=2.33 vs 治疗后M=2.88,p=.005)。
  • 假治疗组前进步速无变化(治疗前M=2.13 vs 1天后M=2.24,p=.537)。
  • 其他所有结局指标均无组间差异,未显示功能性改善。

核心结论

  • 棱镜适应不能改善帕金森病的步态或姿势控制。

研究设计与样本

  • 平行、双盲、随机、假对照试验,招募40-85岁符合三项临床标准之一的特发性帕金森病患者,随机分配至两周每日两次棱镜适应或假治疗。

主要发现

  • 棱镜适应组稳定性极限测试前进步速增加(治疗前M=2.33,SEM=0.24;治疗后M=2.88,SEM=0.26;t(15)=3.2,p=.005,d=.819)。
  • 假治疗组前进步速无变化(治疗前M=2.13,SEM=0.22;1天后M=2.24,SEM=0.22;t(13)=.636,p=.537,d=.176)。
  • 其他所有结局指标均无组间差异,无迹象表明棱镜适应在姿势、步态或日常生活活动方面产生功能性改善。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gait difficulties in Parkinson's disease have been related to problems shifting the center of gravity forward. We previously showed reduced forward stepping latencies for people with Parkinson's disease after one session of adaptation to upward visual shifts, which produces downward motor after-effects and potentially shifts the center of gravity forward. Here we tested if repeated prism adaptation improved gait and postural control in Parkinson's disease through a parallel, double-blind, randomized, sham-controlled trial. METHODS: We recruited participants with idiopathic Parkinson's disease aged 40-85 and meeting any one of three clinical criteria: (1) Hoehn and Yahr Stage II.5-IV; (2) scoring > 0 on the gait, freezing of gait, and/or postural stability items of the Movement Disorder Society Unified Parkinson's Disease Rating Scale; or (3) Timed Up and Go > 12 s. Sealed envelope style randomization allocated participants to two weeks of twice-daily prism adaptation or sham treatment. Participants, care givers, and those assessing the outcomes were blinded to group assignment. Primary outcomes were changes in postural control measured using the Berg Balance Scale and the Limits of Stability, Sensory Organization, and Motor Control tests from the Smart EquiTest system. Secondary outcomes included other physiotherapy and questionnaire measures. Outcomes were assessed at the Dartmouth Hitchcock Medical Center immediately before and after the treatment period, with further long-term postal follow-up over 3 months. Outcomes were analyzed using analyses of variance with follow-up t tests. RESULTS: Eighteen participants were allocated to undergo prism adaptation, of which sixteen were analyzed. Thirteen participants were allocated to undergo sham treatment, and all were analyzed. The prism adaptation group showed increased forward stepping velocity on the Limits of Stability test (pre: M=2.33, SEM=0.24; post: M=2.88, SEM=0.26; t(15)=3.2, p=.005, d=.819). The sham group showed no such change (pre: M=2.13, SEM=0.22; 1d post: M=2.24, SEM=0.22; t(13)=.636, p=.537, d=.176). However, there were no group differences for any other outcome measures and no indications that prism adaptation produced functional improvements in posture, gait, or activities of daily living. CONCLUSIONS: Prism adaptation does not improve gait or postural control in Parkinson's disease. TRIAL REGISTRATION: ClinicalTrials.gov NCT02380859 . Registered prospectively on 5 March 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bultitude JH, Pidgeon DM, LeBlanc PR, et al. Two weeks of twice-daily prism adaptation treatment does not improve posture or gait in Parkinson's disease: a double-blind randomized controlled trial. Trials. 2021. PMID: 34823572. doi:10.1186/s13063-021-05832-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。